论文部分内容阅读
胸腺免疫制剂为新型的免疫调节剂。有胸腺肽(TP)、胸腺素(TS)、胸腺因子(TF)、胸腺因子_D(TF_D)、胸腺原、胸腺免疫抑制提取物(TISH)等药物。是从人、猪、牛等胸腺组织中提取的多种能调节免疫细胞功能的重要的多肽类生物活性物质。动物实验,25～100μg·ml~(-1)的TP对小鼠T细胞增殖和mIL-2R的表达均有促进作用;TS能刺激骨髓产生的干细胞转化为T淋巴细胞,增强机体的细胞免疫功能;调节T-B细胞的平衡作用,抑制B细胞相对功能亢盛所致中种脏器组织损伤。随着医药学研究不断发展,胸腺免疫制剂对各种疾病的治疗及
Thymus immune agent is a new type of immunomodulator. There are thymosin (TP), thymosin (TS), thymus factor (TF), thymus factor _D (TF_D), thymus, thymus immunosuppressive extract (TISH) and other drugs. It is an important peptide bioactive substance extracted from thymus tissues such as human, pig and cattle, which can regulate the function of immune cells. Animal experiments, 25 ~ 100μg · ml -1 of TP on mouse T cell proliferation and mIL-2R expression were promoted; TS can stimulate bone marrow-derived stem cells into T lymphocytes and enhance the body’s cellular immunity Function; regulate the balance of the role of TB cells, inhibit the relative function of B cells caused by various organs in tissue damage. With the continuous development of medical research, thymus immune agents for the treatment of various diseases and